143 related articles for article (PubMed ID: 21933664)
21. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
Schnell D; Burleigh K; Trick J; Seifert R
J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
[TBL] [Abstract][Full Text] [Related]
22. Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):253-64. PubMed ID: 17999052
[TBL] [Abstract][Full Text] [Related]
23. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
24. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens.
Bruysters M; Pertz HH; Teunissen A; Bakker RA; Gillard M; Chatelain P; Schunack W; Timmerman H; Leurs R
Eur J Pharmacol; 2004 Mar; 487(1-3):55-63. PubMed ID: 15033376
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Bucholtz EC; Brown RL; Tropsha A; Booth RG; Wyrick SD
J Med Chem; 1999 Aug; 42(16):3041-54. PubMed ID: 10447948
[TBL] [Abstract][Full Text] [Related]
27. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
28. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
29. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands.
Schneider EH; Seifert R
Biochem Pharmacol; 2009 Sep; 78(6):607-16. PubMed ID: 19464266
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
[TBL] [Abstract][Full Text] [Related]
31. Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes.
Villemain FM; Bach JF; Chatenoud LM
J Immunol; 1990 Feb; 144(4):1449-54. PubMed ID: 1968079
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
33. N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.
Kraus A; Ghorai P; Birnkammer T; Schnell D; Elz S; Seifert R; Dove S; Bernhardt G; Buschauer A
ChemMedChem; 2009 Feb; 4(2):232-40. PubMed ID: 19072936
[TBL] [Abstract][Full Text] [Related]
34. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
35. Modulation of histamine H(3) receptor function by monovalent ions.
Schnell D; Seifert R
Neurosci Lett; 2010 Mar; 472(2):114-8. PubMed ID: 20132865
[TBL] [Abstract][Full Text] [Related]
36. pH-dependent complexation of histamine H1 receptor antagonists and human serum albumin studied by UV resonance Raman spectroscopy.
Tardioli S; Buijs J; Gooijer C; van der Zwan G
J Phys Chem B; 2012 Mar; 116(12):3808-15. PubMed ID: 22372713
[TBL] [Abstract][Full Text] [Related]
37. Linking agonist binding to histamine H1 receptor activation.
Jongejan A; Bruysters M; Ballesteros JA; Haaksma E; Bakker RA; Pardo L; Leurs R
Nat Chem Biol; 2005 Jul; 1(2):98-103. PubMed ID: 16408006
[TBL] [Abstract][Full Text] [Related]
38. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
39. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
Yeramian E; Garbarg M; Schwartz JC
Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
[TBL] [Abstract][Full Text] [Related]
40. Temperature-dependence of the kinetics of the binding of [3H]-(+)-N-methyl-4-methyldiphenhydramine to the histamine H1-receptor: comparison with the kinetics of [3H]-mepyramine.
Treherne JM; Young JM
Br J Pharmacol; 1988 Jul; 94(3):811-22. PubMed ID: 3179614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
